81: Hyperhydrosis and Anhidrosis Flashcards
What is hyperhidrosis and how does it differ from anhidrosis?
Hyperhidrosis is excessive sweating beyond what is physiologically necessary to maintain normal body temperature, while anhidrosis is the inability to generate sweat when it is physiologically necessary to dissipate heat, which can lead to medical emergencies like hyperthermia or heat stroke.
What are the clinical features of primary focal hyperhidrosis?
The clinical features of primary focal hyperhidrosis include:
- Excessive sweating at baseline in various anatomical locations (palms, soles, axillae, craniofacial region, groin).
- Affects both males and females equally.
- Begins in childhood (palmar-plantar) or during puberty (axillary).
- Persists into adulthood and rarely improves spontaneously.
- Severity ranges from mild (moist skin) to severe (dripping wet).
What are the diagnostic criteria for hyperhidrosis?
The diagnostic criteria for hyperhidrosis include:
- Focal visible excessive sweating for ≥6 months without apparent cause.
- At least two of the following:
- Bilateral and relatively symmetric sweating.
- Age of onset typically before age 25 years.
- Cessation of sweating from the focal areas during sleep.
- Frequency of at least once per week.
- Positive family history.
- Sweating impairs daily activities.
What triggers hyperhidrosis?
Triggers for hyperhidrosis include:
- Increased temperature.
- Anxiety.
- Stress.
- Physical activity.
What are the first-line treatment options for hyperhidrosis?
First-line treatment options for hyperhidrosis include:
- Over-the-counter antiperspirants.
- Aluminum chloride hexahydrate (10% to 35%), which is best applied to dry skin at bedtime and washed off after 6 to 8 hours.
If moisture is present when applied, it can form a weak hydrochloric acid, causing burning, irritation, or desquamation.
What is the most likely diagnosis for a patient with excessive sweating on their palms and soles that worsens during stress?
The most likely diagnosis is Primary Focal Hyperhidrosis. Diagnostic criteria include focal visible excessive sweating for ≥6 months without apparent cause and at least two of the following: bilateral and symmetric sweating, onset before age 25, cessation during sleep, frequency of at least once per week, positive family history, and impairment of daily activities.
What is the next step in treatment for severe axillary sweating that has not responded to over-the-counter antiperspirants?
The next step is the application of aluminum chloride hexahydrate (10%-35%), which is best applied to dry skin at bedtime and washed off after 6-8 hours. It works by forming a weak hydrochloric acid that blocks sweat ducts.
What are the key diagnostic criteria for focal visible excessive sweating classified as hyperhidrosis?
The diagnostic criteria for hyperhidrosis include:
- Focal visible excessive sweating for ≥6 months without apparent cause
- At least two of the following:
- Bilateral and relatively symmetric sweating
- Age of onset typically before age 25
- Cessation of sweating from the focal areas during sleep
- Frequency of at least once per week
- Positive family history
- Sweating impairs daily activities.
What are the common triggers for primary hyperhidrosis?
Common triggers for primary hyperhidrosis include:
- Increased temperature
- Anxiety
- Stress
- Physical activity.
What are the clinical features of primary focal hyperhidrosis?
Clinical features of primary focal hyperhidrosis include:
- Excessive sweating at baseline in various anatomic locations (palms, soles, axillae, craniofacial region, groin)
- Affects both males and females equally
- Begins in childhood (palmar-plantar) or during puberty (axillary)
- Persists into adulthood
- Ranges from mild (moist skin) to severe (dripping wet) excessive sweating.
What is the first-line therapy for managing hyperhidrosis?
The first-line therapy for managing hyperhidrosis includes:
- Over-the-counter antiperspirants
- Aluminum chloride hexahydrate (10% to 35%)
Application Instructions:
- Best applied to dry skin at bedtime
- Washed off after 6 to 8 hours
- Caution: If moisture is present during application, it can lead to burning, irritation, or desquamation due to hydrochloric acid formation.
What are the potential medical complications associated with primary hyperhidrosis?
Potential medical complications associated with primary hyperhidrosis include:
- Maceration
- Secondary infections
- Pitted keratolysis
- Dermatophytosis
- Verruca vulgaris or plantaris.
What is the mechanism of action of Botulinum Toxin in treating hyperhidrosis?
Botulinum Toxin acts on the cholinergic synapses by inhibiting acetylcholine release, which helps reduce sweating in the treated areas.
What are the side effects associated with Glycopyrrolate when used for hyperhidrosis?
Side effects of Glycopyrrolate include:
- Erythema
- Mild pain or discomfort
- Paresthesia in the treatment zone.
What is the purpose of Endoscopic Thoracic Sympathectomy (ETS) in hyperhidrosis treatment?
ETS is used for severe cases of palmar hyperhidrosis that have failed conservative management. It can lead to complications such as compensatory sweating in other body segments and other serious risks.
What is the FDA-approved use of miraDry in hyperhidrosis treatment?
miraDry is an FDA-approved procedure for adults with primary axillary hyperhidrosis. It uses microwave energy to permanently destroy eccrine glands, reducing sweating in the treated area.
What is the recommended maintenance frequency for Tap Water Iontophoresis Therapy after initial treatments?
After initial treatments, Tap Water Iontophoresis Therapy typically requires maintenance treatments 1-2 times per week to sustain its effects.
What are the contraindications for using oral anticholinergic agents like Glycopyrrolate and Clonidine?
Oral anticholinergic agents are contraindicated in:
- Myasthenia gravis
- Paralytic ileus
- Pyloric stenosis
Caution is also advised in patients with closed-angle glaucoma, bladder outflow obstruction, gastroesophageal reflux disease, and cardiac insufficiency.
What is the mechanism of action of topical glycopyrrolate in treating craniofacial hyperhidrosis?
Topical glycopyrrolate is an anticholinergic agent that inhibits acetylcholine at muscarinic receptors, reducing sweat production.
What surgical option is available for a patient with severe palmar hyperhidrosis who has failed conservative management?
Endoscopic Thoracic Sympathectomy (ETS) is an option. Potential complications include compensatory sweating, Horner syndrome, bradycardia, pneumothorax, pleural effusion, acute bleeding, delayed hemothorax, chylothorax, and persistent intercostal neuralgia.
What is the duration of efficacy for botulinum toxin injections in axillary hyperhidrosis?
The median duration of efficacy is 4-5 months. Off-label areas include the face, scalp, palms, soles, inframammary folds, and inguinal folds.
What is the rationale for using propranolol in managing stress-induced hyperhidrosis?
Propranolol, a beta-blocker, is effective in managing stress-induced hyperhidrosis by reducing the physiological effects of stress on sweat production.
What are the clinical implications of using Botulinum Toxin for treating hyperhidrosis?
Botulinum Toxin acts on the cholinergic synapses by inhibiting acetylcholine release, which reduces sweating. It is effective for patients who do not respond to topical therapies and has a median duration of effect of 4 to 5 months. It is FDA-approved for severe primary axillary hyperhidrosis in adults 18 years and older, and can also be used off-label for other focal areas such as the face, scalp, and palms.
What are the potential complications associated with Endoscopic Thoracic Sympathectomy (ETS) for palmar hyperhidrosis?
Complications of ETS include:
1. Increased risk of compensatory sweating in body segments below the treated area.
2. Less common complications such as Horner syndrome, bradycardia, and pneumothorax requiring chest tube drainage.
3. Other risks include pleural effusion, acute bleeding, delayed hemothorax, chylothorax, and persistent intercostal neuralgia.